Adiponectin, leptin, resistin and insulin blood concentrations in patients with ischaemic cerebral stroke

Endokrynologia Polska

Volumn 63, Issue 5, 2012, Pages 338-345

  Bienek, Radosław ^a   Marek, Bogdan ^a,b   Kajdaniuk, Dariusz ^a,b   Borgiel Marek, Halina ^b   Piecha, Tomasz ^c   Nowak, Mariusz ^b   Siemiñska, Lucyna ^b   Głogowska Szela̧g, Joanna ^b   Foltyn, Wanda ^b   Kos Kudła, Beata ^b  

^a Voivodeship Specialistic Hospital No 3   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN; RESISTIN;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BLOOD SAMPLING; BRAIN ISCHEMIA; CHEMICAL ANALYSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SURVIVOR;

EID: 84870920267     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Litwin T, Kobayashi A, Skowrońska M et al. Thrombolysis in acute ischaemic stroke within 3 hours of symptom onset: a report of the first 100 cases. Neurol Neurochir Pol 2008; 42: 1-5. (Pubitemid 351493446)
2. Kobayashi A, Członkowska A. Trombolysis in acute ischemic stroke. Farmakoter Psychiatr Neurol 2005; 1: 5-18.
3. Centurion OA. Actual Role of Platlet Glycoprotein IIb/IIIa Receptor Inhibitors as Adjunctive Pharmacological Therapy to Primary Angioplasty in acute Myocardial Infarction: In the Light of Recent Randomized Trials and Observational Studies with Bivalirudin. Open Cardiovasc Med J 2010; 4: 135-45.
4. Gahn G, Barlinn K, Dzialowski I et al. Combined thrombolysis with abciximab and rtPA in patients with middle cerebral artery occlusion. Acta Neurol Scand 2010; 121: 63-66.
5. Gnacińska M, Małgorzewicz S, Lysiak-Szydłowska W et al. The serum profile of adipokines In overweight patients with metabolic syndrome. Endokrynol Pol 2010; 61: 36-41.
6. Szopa M, Dȩbińska-Kieć A. Visfatin - new adipokine. Diabetol Prakt 2005; 6: 266-269.
7. Lago F, Dieques C, Gómez-Reino J et al. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol 2007; 3: 716-724. (Pubitemid 350187017)
8. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556. (Pubitemid 38766330)
9. Siemińska L, Cichoń-Lenart A, Kajdaniuk D et al. Sex hormones and adipocytokines In postmenopausal women. Pol Merkur Lekarski 2006; 20: 727-730. (Pubitemid 44084971)
10. Szopa M, Skupień J. Omentin a new adipokine within the new definition of the metabolic syndrome (IDF 2005). Diabetol Prakt 2007; 8: 35-39.
11. Psurek A, Szymborska-Kajanek A. Obesity and cardiometabolic risk. Przew Lek 2008; 3: 10-17.
12. Niemczyk S, Romejko-Cieplewska K, Niemczyk L. Adipocytokines and sex hormone disorders in patients with chronic renal failure (CRF). Endokrynol Pol 2012; 63: 148-155.
13. Koroglu BK, Kiris F, Ersoy IH et al. Relation of leptin, adiponectin and insulin resistance to bone mineral density in type 2 diabetic postmenopausal women. Endokrynol Pol 2011; 62: 429-35.
14. Kozłowska A, Kowalska I. The adiponectin role In pathogenesis of metabolic syndrome and cardiovascular disease. Endokrynol Pol 2006; 6: 626-632.
15. Karbowska J, Warczak E, Kochan Z. Adiponectin gene polymorphism and protein dysfunction in the development of insulin resistance. Postepy Hig Med Dosw 2004; 58: 449-457.
16. Sada KE, Yamasaki Y, Maruyama M et al. Altered levels of adipocytokines in association with insulin resistance in patients with SLE. J Reumatol 2006; 33: 1545-1552. (Pubitemid 44168825)
17. Pischon T, Girman CJ, Hotamisligil GS et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730-1737. (Pubitemid 38489895)
18. Wolk R, Berger P, Lennon RJ et al. Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 2007; 28: 292-298.
19. Komjia S, Funahashi T, Sakamoto T et al. The variation of plasma concentrations of novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003; 89: 667-668. (Pubitemid 36606220)
20. Otero M, Lago M, Gomez R et al. Changes In plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1198-1201. (Pubitemid 44277396)
21. Bogdański P, Musialik K, Szulińska M et al. Evaluation of serum resistin level in hypertensive patients with metabolic syndrome. Endokrynologia Otyłość i Zaburzenia Przemiany Materii 2006; 2: 116-121.
22. Efstathiou SP, Tsioulos DI, Tsiakou AG et al. Plasma adiponectin levels and five-years survival after first-ever ischemic stroke. Stroke 2005; 36: 1915-1919. (Pubitemid 41266526)
23. Chandran M, Philips SA, Ciaraldi T et al. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003; 26: 2442-2450. (Pubitemid 36993340)
24. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI et al. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J) 2007; 83 (Suppl. 5): S193-203.
25. Chen MP, Tsai JC, Chung FM et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 821-826. (Pubitemid 40463876)
26. Matsumoto M, Ishikawa S, Kajii E. Association of adiponectin with cerebrovascular disease: a neasted case-control study. Stroke 2008; 39: 323-328. (Pubitemid 351619450)
27. Pyzik M. Leptin level in ischemic stroke. Pol Merkur Lekarski 2010; 28: 371-375.
28. Weikert C, Wetsphal S, Berger K et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab 2008; 93: 2647-2653. (Pubitemid 352008532)
29. Berg AH, Scherer PE. Adipose tissue, inflammation and cardiovascular disease. Circ Res 2005; 96: 939-949. (Pubitemid 40712793)
30. Shetty G, Economides PA, Horton ES et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004; 27: 2450-2457. (Pubitemid 39281400)
31. Pan W, Yu C, Hsuchou H et al. Neuroinflammation facilitates LIF entry into brain: role of TNF. Am J Physiol Cell Physiol 2008; 294: 1436-1442.
32. Tucholski K, Otto-Buczkowska E. The role of leptin in the regulation of carbohydrate metabolism. Endokrynol Pol 2011; 62: 258-262.
33. Jankiewicz-Wika J, Kołomecki K, Cywiński J et al. Impact of vertical banded gastroplasty on body weight, insulin resistance, adipocytokine, inflammation and metabolic syndrome markers in morbidly obese patients. Endokrynol Pol 2011; 62: 109-119.
34. Sandhofer A, Laimer M, Ebenbichler CF et al. Soluble leptin receptor and soluble receptor-bound fraction of leptin in metabolic syndrome. Obes Res 2003; 11: 760-768. (Pubitemid 41151602)
35. Schultze PC, Kratzsch J, Linke A et al. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail 2003; 5: 33-40. (Pubitemid 36205542)
36. Siemińska L, Wojciechowska C, Kos-Kudła B et al. Serum concentrations of leptin, adiponectin, and interleukin-6 in postmenopausal women with Hashimoto's thyroiditis. Endokrynol Pol 2010; 61: 112-116.
37. Kos H, Harte AL, da Silva NF et al. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 2007; 92: 1129-136. (Pubitemid 46465692)
38. 125I] leptin binding sites in rat forebrain. Brain Res 1998; 789: 40-47.
39. Lau DC, Dhillon B, Yan H et al. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005; 288: H2031-H2041. (Pubitemid 40604084)
40. Bełtowski J. Leptin and atherosclerosis. Atherosclerosis 2006; 189: 47-60. (Pubitemid 44441296)
41. Cao H, Hegele R. Single nucleotide polymorphisms of the resisint (RSTN) gene. J Hum Genet 2001; 46: 553-555. (Pubitemid 32847573)
42. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 2004; 50: 1511-1525. (Pubitemid 39121218)
43. Reilly MP, Lehrke M, Wolfe ML et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005; 111: 932-939. (Pubitemid 40279897)
44. Calabro P, Samudio I Resistin promotes smooth muscle proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 2004; 110: 3335-3340. (Pubitemid 39557496)
45. Efstathiou SP, Tsiakou AG, Tsioulos DI et al. Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta 2007; 378: 78-85.
46. Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke 2004; 35: 363-364. (Pubitemid 38174407)
47. Kuusisto J, Mykkänen L, Pyörälä K et al. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 1994; 25: 1157-1164. (Pubitemid 24164754)
48. Shinozaki K, Naritomi H, Shimizu T et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996; 27: 37-43. (Pubitemid 26008292)
49. Urabe T, Watada H, Okuma Y et al. Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in Japanese patients. Stroke 2009; 40: 1289-1295.
50. Osawa H, Doi Y. Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: a Hisayama Study. Cardiovasc Diabetol 2009; 8: 60.
51. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-141. (Pubitemid 9238735)
52. Ksia̧żek K, Witowski J. Impaired insulin signaling and human ageing. Postepy Hig Med Dosw (Online) 2008; 62: 263-271.
53. Gertler MM, Leetma HE, Koutriuby RJ et al. The assesment of insulin, glucose and lipids in ischemic thrombotic cerebrovascular disease. Stroke 1975; 6: 77-84.
54. Wannamethee SG, Perry IJ, Sharper AG. Nonfasting serum glucose and insulin concentrations ant the risk of stroke. Stroke 1999; 30: 1780-1786. (Pubitemid 29411814)
55. Zhang YF, Hong J, Zhan WW et al. Hyperglycaemia after glucose loading is a major predictor of preclinical atherosclerosis in nondiabetic subjects. Clin Endocrinol (Oxf) 2006; 64: 153-157.
56. Pyörälä M, Miettinen H, Halonen P et al. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middleaged men: the 22-year follow-up results of the Helsinki Policemen Study. Atheroscler Thromb Vasc Biol 2000; 20: 538-544. (Pubitemid 30086114)
57. Lidahl B, Dinesen B, Eliasson M et al. High proinsulin level precede first-ever stroke in nondiabetic population. Stroke 2000; 31: 293-241.
58. Ryan AS, Macko RF, Peters MN et al. Plasma adiponectin level are associated with insulin sensitivity in stroke survivors. J Stroke Cerebrovasc Dis 2009; 18: 214-220.
59. Marousi SG, Theodorou GL, Karakantza M et al. Acute post-stroke adiponectin in relation to stroke severity, progression and 6 month functional outcome. Neurol Res 2010; 32: 841-844.
60. Lim S, Koo BK, Cho SW et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis 2008; 196: 398-404.
61. Okamoto H. Can adiponectin be a novel metabolic biomarker for heart failure? Circ J 2009; 73: 1012-1013.
62. Norata GD, Raselli S, Grigore L et al. Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 2007; 38: 2844-2846. (Pubitemid 47494027)
63. Kawano T, Saito T, Yasu T et al. Close association of hypoadiponectinemia with atherosclerosis obliterans and ischemic heart disease. Metabolism 2005; 54: 653-656. (Pubitemid 40585655)
64. Chen B, Liao WQ, Xu N et al. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res 2009; 1273: 129-137.
65. Stott DJ, Welsh P, Rumley A et al. Adipokines and risk of stroke in older people: a nested case-control study. Int J Epidemiol 2009; 38: 253-264.
66. Söderberg S, Stegmayr B, Stenlund H et al. Leptin, but not adiponectin, predicts strole in males. J Intern Med 2004; 256: 128-136. (Pubitemid 38998259)
67. Söderberg S, Ahren B, Stegmayr B et al. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 1999; 30: 328-337. (Pubitemid 29071798)
68. Thogersen AM, Söderberg S, Jansson JH et al. Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction. Eur J Cardiovasc Prev Rehabil 2004; 11: 33-40. (Pubitemid 38388922)
69. Wallerstedt SM, Eriksson AL, Niklason A et al. Serum leptin and myocardial infarction in hypertension. Blood Press 2004; 13: 243-246. (Pubitemid 39248188)
70. Wolk R, Berger P, Lennon RL et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Cardiol 2004; 44: 1819-1824. (Pubitemid 39424081)
71. Ciccone M, Vettor R, Pannacciulli N et al. Plasma leptin is independently associated with intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 2001; 25: 805-810. (Pubitemid 32601372)
72. Valerio A, Dossena M, Bertolotti P et al. Leptin is induced in the ischemic cerebral cortex and exerts neuroprotection through NF-kappaB/c-Rel- dependent transcription. Stroke 2009; 40: 610-617.
73. Szulińska M, Pupek-Musialik D. Resistin - the role of development of insulin resistance - facts and controversy. Nadciśnienie Tȩtnicze 2006; 10: 301-306. (Pubitemid 44639167)
74. Steppan CM, Brown EJ, Wright CM et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001; 98: 502-506. (Pubitemid 32105071)
75. Steppan CM, Wang J, Whiteman EL et al. Activation of SOCS-3 by resistin. Mol Cell Biol 2005; 25: 1569-1575. (Pubitemid 40204931)
76. Vozarova De Courten B, Degawa-Yamauchi M, Considine RV et al. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indian. Diabetes 2004; 53: 1279-1284. (Pubitemid 38569014)
77. Tsukahara T, Nakashima E, Watarai A et al. Polymorphism in resistin promoter region AT-420 determines the serum resistin level and may be a risk marker of stroke in Japanese type 2 diabetic patient. Diabetes Res Clin Pract 2009; 84: 179-186.
78. Kurrimbux D, Graffen Z, Farrel CL et al. The involvement of the blood-brain and the blood-cerebrospinal fluid barriers in the distribution of leptin into and out of the rat brain. Neuroscience 2004; 123: 527-536. (Pubitemid 38032928)